Serina Therapeutics Publishes Invited Manuscript on Tuning Drug Delivery By 100 Danish|2019-10-14T16:18:16+00:00October 14th, 2019|News|0 Comments Share This Story, Choose Your Platform! About the Author: 100 Danish Related Posts Serina Therapeutics Announces Publication of SER-214 Clinical Trial Results Serina Therapeutics Announces Publication of SER-214 Clinical Trial Results Dr. Randall Moreadith, President and CEO, will Present at Biotech Showcase During the Annual JP Morgan Healthcare Conference Dr. Randall Moreadith, President and CEO, will Present at Biotech Showcase During the Annual JP Morgan Healthcare Conference Serina Therapeutics Announces Dr. William K. Schmidt will Join the Clinical Advisory Board. Serina Therapeutics Announces Dr. William K. Schmidt will Join the Clinical Advisory Board. Serina Therapeutics Receives NIH Grant to Develop SER-227 for Post-Operative Pain Serina Therapeutics Receives NIH Grant to Develop SER-227 for Post-Operative Pain Serina Announces CEO Will Present at Neurotech Investing and Partnership 2019 Serina Announces CEO Will Present at Neurotech Investing and Partnership 2019